diadenosine tetraphosphate has been researched along with uridine triphosphate in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 6 (50.00) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jacobson, KA; Jarvis, MF; Williams, M | 1 |
Hillmann, P; Höltje, HD; Ko, GY; Kostenis, E; Müller, CE; Nicholas, RA; Raulf, A; Spinrath, A; von Kügelgen, I; Wolff, SC | 1 |
Camden, J; Fischer, B; Weisman, GA; Yelovitch, S | 1 |
Flodgaard, H; Hedman, C; Winther, K | 1 |
Andersson, M; Lewan, L | 1 |
Boucher, RC; Harden, TK; Lazarowski, ER; Stutts, MJ; Watt, WC | 1 |
Bailey, SJ; Hourani, SM; Johnson, CR; Tennant, JP | 1 |
Laubinger, W; Reiser, G; Streubel, G | 1 |
Barnes, A; Boughtflower, R; Camacho, J; Cousens, D; Marshall, F; Patel, K; Paterson, C | 1 |
Bautista, A; Carracedo, G; Peral, A; Pintor, J | 1 |
Lee, SY; Müller, CE; Namasivayam, V | 1 |
Harden, TK; Herold, CL; Kennedy, C; Nicholas, RA; Qi, AD | 1 |
1 review(s) available for diadenosine tetraphosphate and uridine triphosphate
Article | Year |
---|---|
Purine and pyrimidine (P2) receptors as drug targets.
Topics: Adenosine Triphosphate; Animals; Drug Design; Humans; Ligands; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyrimidines; Receptors, Purinergic P2; Uridine Triphosphate | 2002 |
1 trial(s) available for diadenosine tetraphosphate and uridine triphosphate
Article | Year |
---|---|
Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade.
Topics: Adenosine Triphosphate; Adult; Blood Platelets; Dinucleoside Phosphates; Female; Humans; Male; Metoprolol; Migraine Disorders; Propranolol; Receptors, Adrenergic, beta; Uridine Triphosphate | 1990 |
10 other study(ies) available for diadenosine tetraphosphate and uridine triphosphate
Article | Year |
---|---|
Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.
Topics: Amino Acid Sequence; Amino Acids; Animals; Cell Line; Disulfides; Drug Design; Enzyme-Linked Immunosorbent Assay; Extracellular Space; Gene Expression; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Nucleotides; Oxidation-Reduction; Protein Structure, Secondary; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Sequence Homology, Amino Acid | 2009 |
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
Topics: Animals; Boranes; Calcium; Cell Line, Tumor; Dinucleoside Phosphates; Drug Stability; Humans; Hydrolysis; Models, Molecular; Molecular Conformation; Phosphoric Diester Hydrolases; Purinergic P2Y Receptor Agonists; Pyrophosphatases; Receptors, Purinergic P2Y; Stereoisomerism; Structure-Activity Relationship; Turkey | 2012 |
Early increase in diadenosine tetraphosphate in regenerating rat liver.
Topics: Adenine Nucleotides; Animals; Cell Division; Chromatography, High Pressure Liquid; Deoxyadenine Nucleotides; Dinucleoside Phosphates; DNA; Liver; Liver Regeneration; Male; Rats; Rats, Inbred Strains; Thymine Nucleotides; Uridine Triphosphate | 1988 |
Pharmacological selectivity of the cloned human P2U-purinoceptor: potent activation by diadenosine tetraphosphate.
Topics: Adenine; Adenine Nucleotides; Astrocytoma; Cloning, Molecular; Dinucleoside Phosphates; Humans; Inositol Phosphates; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Second Messenger Systems; Sensitivity and Specificity; Transfection; Tritium; Tumor Cells, Cultured; Uridine Triphosphate | 1995 |
Effects of adenosine 5'-triphosphate, uridine 5'-triphosphate, adenosine 5'-tetraphosphate and diadenosine polyphosphates in guinea-pig taenia caeci and rat colon muscularis mucosae.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Colon; Dinucleoside Phosphates; Guinea Pigs; Male; Rats; Rats, Wistar; Suramin; Uridine Triphosphate | 1998 |
Physiological evidence for a P2Y receptor responsive to diadenosine polyphosphates in human lung via Ca(2+) release studies in bronchial epithelial cells.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Bronchi; Calcium; Cells, Cultured; Chromatography, High Pressure Liquid; Dinucleoside Phosphates; Epithelial Cells; Humans; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Uridine Triphosphate | 2001 |
Activity of diadenosine polyphosphates at P2Y receptors stably expressed in 1321N1 cells.
Topics: Adenosine Diphosphate; Calcium; Carbachol; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Gene Expression; Humans; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Tumor Cells, Cultured; Uridine Triphosphate | 2001 |
UTP and diadenosine tetraphosphate accelerate wound healing in the rabbit cornea.
Topics: Animals; Cornea; Corneal Injuries; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Epithelium; Male; Mitogen-Activated Protein Kinases; Nucleotides; Phosphorylation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rabbits; Signal Transduction; Uridine Triphosphate; Wound Healing | 2004 |
The promiscuous ectonucleotidase NPP1: molecular insights into substrate binding and hydrolysis.
Topics: Adenosine Triphosphate; Amino Acids; Binding Sites; Cyclic AMP; Cyclic GMP; Dinucleoside Phosphates; Humans; Hydrolysis; Phosphoric Diester Hydrolases; Protein Binding; Pyrophosphatases; Substrate Specificity; Thymidine Monophosphate; Uridine Triphosphate | 2017 |
ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Dinucleoside Phosphates; Humans; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Species Specificity; Tumor Cells, Cultured; Uridine Diphosphate | 2000 |